Obalon Therapeutics, Inc. Announces Two Agreements To Provide Up To $30 Million of Capital Stockhouse
SAN DIEGO, Dec. 27, 2018 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (Nasdaq: OBLN), a vertically integrated medical technology company with the first …